SCHEMBL5344949

SCHEMBL5344949

COc1cccc2c1ccc1c(O)cc(=O)oc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.51
MCL1 Q07820 4/20 0.50
MAOA P21397 5/20 0.49
CYP2A6 P11509 2/20 0.49
PRKDC P78527 1/20 0.46
EGFR P00533 1/20 0.46
KDR P35968 1/20 0.46
ANTXR2 P58335 1/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5348687 0.89 MAOA (0.56) METMCL1MAOACYP2A6PRKDC
SCHEMBL3587194 0.87 CA12 (0.50) METMCL1MAOAEGFRKDR
SCHEMBL3575287 0.80 MET (0.56) METMCL1MAOAKDM4EALDH1A1
SCHEMBL8442563 0.79 HPGD (0.72) METMCL1MAOAEGFRKDR
SCHEMBL3585887 0.78 MET (0.53) METMCL1KDM4EALDH1A1MEN1
SCHEMBL31444051 0.77 MET (0.45) METMCL1MAOAPRKDCANTXR2
SCHEMBL28480556 0.76 MET (0.61) METMCL1MAOAEGFRKDM4E
SCHEMBL30693881 0.76 MET (0.61) METMCL1MAOAEGFRKDM4E
SCHEMBL2761835 0.74 MET (0.56) METMCL1MAOAPRKDCKDM4E
SCHEMBL15842289 0.74 PRKDC (0.59) MCL1MAOACYP2A6PRKDCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action PLIVA-LSTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action LTC4S, CYP11B2, CYP11B1 MET 3947/4885MCL1 4672/4885MAOA 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.